Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. (Q50908731)

25 March 2018

title

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. (English)

1 reference

25 March 2018

main subject

ventricular dysfunction

1 reference

left ventricular dysfunction

inferred from title

1 reference

Al-Khadra AS

1

1 reference

25 March 2018

Salem DN

2

1 reference

25 March 2018

Rand WM

3

1 reference

25 March 2018

Udelson JE

4

1 reference

25 March 2018

Smith JJ

5

1 reference

25 March 2018

Konstam MA

6

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

25 March 2018

Journal of the American College of Cardiology

published in

1 reference

25 March 2018

volume

31

1 reference

25 March 2018

issue

2

1 reference

25 March 2018

page(s)

419-425

1 reference

25 March 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Nonsteroidal anti-inflammatory drugs and antihypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Effects of acetylsalicylic acid on renal function in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Expression of inducible nitric oxide synthase in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Increased production of nitric oxide in coronary arteries during congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

Increase in Prostaglandins during Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900502-0

7 January 2021

10.1016/S0735-1097(97)00502-0

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018